Friday, February 3, 2023

Partner Profiles

Defence Therapeutics begin toxicology study of intranasal AccutoxTM

Defence Therapeutics begin toxicology study on intranasal AccutoxTM

Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce the start...
Defence Therapeutics has melanoma vaccine validated

Defence Therapeutics has melanoma vaccine validated

Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the validation...
Defence Therapeutics has US patent accepted for Accum

Defence Therapeutics has US patent accepted for Accum

Defence Therapeutics Inc, a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery technologies including Antibody Drug Conjugate...


Pin It on Pinterest